Señales en vivo de ABCL | Maximiza tus Ganancias con Getagraph.com

VENDER 119280 min ago

@ $5.26

Emitido: 14 feb 2024 @ 14:38

Retorno: -21.03%

Señal anterior: feb 14 - 12:00

Señal anterior: Comprar

Retorno: 1.06 %

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 11:39):

Stats
Volumen de hoy	843 734
Volumen promedio	1.39M
Capitalización de mercado	1.22B
EPS	$0 ( 2024-05-02 )
Próxima fecha de ganancias	( $0 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.14
ATR14	$0.0120 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-26	Hansen Carl L. G.	Sell	56 125	Share option (right to buy)
2024-02-26	Hansen Carl L. G.	Buy	56 125	Common Shares
2024-01-14	Lecault Veronique	Buy	770 416	Share option (right to buy)
2024-01-14	Stimart Tryn	Buy	616 333	Share option (right to buy)
2024-01-14	Booth Andrew	Buy	770 416	Share option (right to buy)

INSIDER POWER
79.71
Last 95 transactions
Buy: 16 009 839 \| Sell: 26 316 378

Volumen Correlación

Largo: -0.04 (neutral)

Corto: 0.87 (strong)

Signal:(22.831) Same movement expected

AbCellera Biologics Inc. Correlación

10 Correlaciones Más Positivas
SVAC	0.967
STOK	0.963
CROX	0.96
GSIT	0.957
CTXR	0.957
VIR	0.955
JBLU	0.954
TPIC	0.953
FGEN	0.952
OPRA	0.95

10 Correlaciones Más Negativas
RMBS	-0.984
NETE	-0.973
AMRB	-0.972
MMAC	-0.956
BRIVU	-0.952
MSDA	-0.95
SCR	-0.95
IMOS	-0.949
KE	-0.948
EBSB	-0.947

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AbCellera Biologics Inc. Correlación - Moneda/Commodity

0.49
( neutral )

0.59
( weak )

0.00
( neutral )

0.29
( neutral )

0.00
( neutral )

0.13
( neutral )

AbCellera Biologics Inc. Finanzas

Annual	2023
Ingresos:	$38.03M
Beneficio Bruto:	$7.13M (18.75 %)
EPS:	$-0.510

FY	2023
Ingresos:	$38.03M
Beneficio Bruto:	$7.13M (18.75 %)
EPS:	$-0.510

FY	2022
Ingresos:	$485.42M
Beneficio Bruto:	$418.99M (86.31 %)
EPS:	$0.560

FY	2021
Ingresos:	$375.20M
Beneficio Bruto:	$329.69M (87.87 %)
EPS:	$0.960

Financial Reports:

No articles found.

AbCellera Biologics Inc.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Actualizaciones en tiempo real para AbCellera Biologics Inc. [ABCL]

Upcoming Earnings Alert